Pricing Log in Create free account

ALX Oncology Holdings Inc. (ALXO) vs Korro Bio, Inc. (KRRO)

ALX Oncology Holdings Inc. and Korro Bio, Inc. are both Biotechnology companies. ALX Oncology Holdings Inc. and Korro Bio, Inc. are of similar size ($138.3M and $137.1M). Across the 13 metrics below, Korro Bio, Inc. leads on 7 and ALX Oncology Holdings Inc. on 6.

Valuation

Metric ALXO KRRO Biotechnology median
P/E n/m n/m 8.42
P/S 55.64 25.66 10.01
P/B 1.00 1.59 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 5.06 10.53 9.41
Earnings yield (113.00%) (107.41%) (31.85%)
Free cash flow yield (52.28%) (41.62%) (24.58%)

Profitability

Metric ALXO KRRO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (80.65%) (97.69%) (56.36%)
Return on assets (63.16%) (62.03%) (48.04%)
Return on invested capital (673.30%) 0.00% 0.00%

Growth

Metric ALXO KRRO Biotechnology median
Revenue growth (TTM) — (81.87%) 6.02%
EPS growth (last fiscal year) 26.36% (33.19%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALXO KRRO Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 9.71 9.55 4.72
Net debt to EBITDA 0.34 0.64 0.96

Dividend

Metric ALXO KRRO Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALXO KRRO Biotechnology median
Market cap 138.28m 137.09m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack